U.S. market Closed. Opens in 17 hours 19 minutes

VERA | Vera Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue-1.86M-846.00K176.00K251.00K509.00K
Gross Profit1.86M846.00K-176.00K-251.00K-509.00K
Operating Expenses103.87M90.90M34.40M49.24M11.70M
Selling, General & Admin21.56M21.91M11.92M4.04M4.41M
Research & Development82.31M68.99M22.48M45.21M7.29M
Other Operating ExpensesN/A1.85M1.79M-1.08MN/A
Operating Income-102.01M-90.90M-34.40M-52.24M-11.96M
Other Expenses / Income6.02M1.85M1.79M-1.17M108.00K
Before Tax Income-95.99M-89.06M-32.61M-53.41M-11.85M
Income Tax Expenses1.00K1.00K1.00K1.00K1.00K
Net Income-95.99M-89.06M-32.61M-53.41M-11.85M
Interest Expenses-3.79M992.00K20.00K166.00K51.00K
Basic Shares Outstanding42.71M26.57M21.28M3.71M3.42M
Diluted Shares Outstanding42.71M26.57M21.28M3.71M3.42M
EBITDA-103.87M-90.90M-34.40M-50.00M-11.03M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-99.78M-88.06M-32.59M-53.25M-11.80M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙